Validation study comparing FACS system and CardioWatch 287 for mental health assessment
Mental health disorders such as anxiety and depression are increasingly recognized as significant public health challenges. Leveraging advanced technologies, including artificial intelligence (AI) and telemonitoring devices, offers a promising path toward improving diagnosis and treatment. This validation study compares the performance of two innovative tools: the FACS system from DYAGNOSYS and the CardioWatch 287 bracelet from CORSANO. Both aim to enhance mental health assessments by providing accurate, reliable, and non-invasive diagnostics.
To determine the accuracy and reliability of the FACS system and CardioWatch 287 bracelet in diagnosing anxiety and depression, using validated questionnaires as a benchmark.
The study involves 240 medical students recruited from the UNIVÉRTIX University Center, representing a population of 636 students. The sample size was determined using the OpenEpi® statistical tool, with a 95% confidence interval and a 5% margin of error.
Participants were invited via email and required to provide formal consent through a signed Informed Consent Form (ICF).
The FACS system uses the Facial Action Coding System to analyze emotional states through video-based facial expressions. It provides standardized scores for stress, anxiety, and depression by quantifying specific Action Units (AUs).
The CardioWatch 287 bracelet tracks various physiological parameters:
These measurements are captured at variable frequencies, enabling high-resolution data collection for mental health assessments.
The study evaluates non-verbal communication parameters to assess emotional and mental states:
Participants are divided into two groups:
The diagnostic outcomes from the FACS system and CardioWatch 287 are cross-referenced with these groups to evaluate accuracy and reliability.
The study aims to establish a strong correlation between the diagnostic data from the FACS system and CardioWatch 287 with results from validated questionnaires. Successful results will demonstrate the devices’ potential for integration into clinical practice, improving accessibility and reliability in mental health diagnostics.